Page 1 | Search Results | Blood | American Society of Hematology

1-16 of 16

Sort by

Sort Order Select

Journal Articles

Prognostication of Diffuse Large B-Cell Lymphoma By Lympho2Cx Assay and BCL2 and MYC Expression: Application in a Real Life Context of 154 Patients

Stefania Bettelli, Raffaella Marcheselli, Samantha Manfredini, Alessia Bari, MD, Samantha Pozzi, MD, M. Christina Christina Cox, MD PhD, Luigi Marcheselli, Arianna Di Napoli, Ilana Levy, MD, Elisa Forti, Tamar Tadmor, MD, Antonino Maiorana, Stefano Sacchi, MD

Blood (2018) 132 (Supplement 1): 5308.

https://doi.org/10.1182/blood-2018-99-117973

Published: 2018

Journal Articles

Absolute Monocyte Count at Diagnosis Could Improve the Prognostic Role of Final FDG-PET in Diffuse Large B Cell Lymphoma Patients

Raffaella Marcheselli, PhD, Antonella Franceschetto, MD, Alessia Bari, MD, Luigi Marcheselli, MS, Tamar Tadmor, MD, Samantha Pozzi, MD, Ilana Levy, MD, Patrizia Pizzichini, MD, Daniela Prosperi, MD, Maria Christina Cox, MD, Rosaria D'Apollo, MD, Lucia Massi, MD, Napoleone Prandini, MD, Stefano Sacchi, MD

Blood (2017) 130 (Supplement 1): 1576.

https://doi.org/10.1182/blood.V130.Suppl_1.1576.1576

Published: 2017

Journal Articles

Prognostic Score Based on Clinical and Biochemical Surrogates of Disease Status in DLBCL Trated with Chemo-Immunotherapy

Luigi Marcheselli, Alessia Bari, MD, Samantha Pozzi, MD, Raffaella Marcheselli, M. Christina Cox, MD, Luca Baldini, Prof, Stefano Luminari, MD, Stefano Sacchi, MD

Blood (2014) 124 (21): 3027.

https://doi.org/10.1182/blood.V124.21.3027.3027

Published: 2014

Journal Articles

Prognostic Role of Serum Albumin Level in DLBCL before and during the Rituximab Era. Retrospective GISL Study over 738 Cases

Luigi Marcheselli, Alessia Bari, MD, Samantha Pozzi, MD, Raffaella Marcheselli, Maria Christina Cox, MD, Luca Baldini, Prof, Stefano Luminari, MD, Stefano Sacchi, MD

Blood (2014) 124 (21): 5411.

https://doi.org/10.1182/blood.V124.21.5411.5411

Published: 2014

Journal Articles

Long-Term Follow-up Analysis of HD2000 Trial Comparing ABVD Versus BEACOPP Versus Copp/EBV/CAD in Patients with Newly Diagnosed Advanced-Stage Hodgkin's Lymphoma: A Study from the Fondazione Italiana Linfomi

Francesco Merli, MD, Stefano Luminari, MD, Caterina Mammi, PhD, Nicola Cascavilla, MD, Alessia Bari, MD, Caterina Stelitano, MD, Renato Scalone, MD, Luca Baldini, Prof, Francesco Angrilli, MD, Giuseppe Polimeno, MD, Paolo G Gobbi, Prof, Giulia Cervetti, MD, Fiorella Ilariucci, MD, Alessia Ruffini, Luigi Marcheselli, Massimo Federico, MD

Blood (2014) 124 (21): 499.

https://doi.org/10.1182/blood.V124.21.499.499

Published: 2014

Journal Articles

Romidepsin and Lenalidomide Show a Synergistic Effect In T–Cell Lymphoma Cell Lines

Maria Cosenza, MS, Monica Civallero, MS, PhD, Stefania Fiorcari, MS, Samantha Pozzi, MD, Luigi Marcheselli, Eliana Valentina Liardo, MD, Alessia Bari, MD, Stefano Sacchi, MD

Blood (2013) 122 (21): 5148.

https://doi.org/10.1182/blood.V122.21.5148.5148

Published: 2013

Journal Articles

Are Absolute Monocyte Count and The Lymphocyte-Monocyte Ratio (LMR) Valid Prognostic Factors In Classical Hodgkin Lymphoma? An Evaluation Based On Data From 1079 Patients

Stefano Sacchi, MD, Alessia Bari, MD, Tamar Tadmor, MD, Luigi Marcheselli, MS, Samantha Pozzi, MD, Eliana Valentina Liardo, MD, Angela Ferrari, MD, Caterina Stelitano, Paolo G Gobbi, Prof, Luca Baldini, Daniele Vallisa, MD, Emilio Iannitto, MD, Aaron Polliack, MD, Massimo Federico

Blood (2013) 122 (21): 1754.

https://doi.org/10.1182/blood.V122.21.1754.1754

Published: 2013

Journal Articles

Final Results Of a Phase II Study Of Lenalidomide In Combination With Rituximab For The Treatment Of Indolent Non Follicular Non Hodgkin Lymphoma

Stefano Sacchi, MD, Samantha Pozzi, MD, Marina Cesaretti, Luigi Marcheselli, MS, Gabriele Buda, MD, Antonio Lazzaro, MD, Luca Baldini, Francesco Di Raimondo, MD, Pellegrino Musto, MD, Alfonso Zaccaria, Giorgina Specchia, Umberto Vitolo, MD, Massimo Magagnoli, MD, Franco Silvestris, MD, Pier Paolo Fattori, MD, Patrizia Tosi, MD, Eliana Valentina Liardo, MD, Alessia Bari, MD, Angelo Michele Carella

Blood (2013) 122 (21): 4383.

https://doi.org/10.1182/blood.V122.21.4383.4383

Published: 2013

Journal Articles

Monocytosis Has Adverse Prognostic Significance and Impacts Survival in Patients with T-Cell Lymphomas.

Stefano Sacchi, Alessia Bari, MD, Tamar Tadmor, MD, Luigi Marcheselli, MS, Eliana Valentina Liardo, Samantha Pozzi, Stefano Luminari, MD, Luca Baldini, MD, Massimo Federico, MD, Aaron Polliack, MD

Blood (2012) 120 (21): 2647.

https://doi.org/10.1182/blood.V120.21.2647.2647

Published: 2012

Journal Articles

In Vitro Combination of Bortezomib with Enzastaurin or Lenalidomide Enhances the Cytotoxicity in B-Cell Lymphoma Cell Lines.

Maria Cosenza, MS, Monica Civallero, MS, PhD, Samantha Pozzi, Alessia Bari, MD, Eliana Valentina Liardo, Stefano Sacchi

Blood (2012) 120 (21): 2754.

https://doi.org/10.1182/blood.V120.21.2754.2754

Published: 2012

Journal Articles

Secondary Leukemia After Non-Hodgkin Lymphoma: A Systematic Review and a Meta-Analysis

Raffaella Marcheselli, MS, Alessia Bari, MD, Eliana Valentina Liardo, MD, Luigi Marcheselli, MS, Samantha Pozzi, MD, Stefano Sacchi, MD

Blood (2011) 118 (21): 5192.

https://doi.org/10.1182/blood.V118.21.5192.5192

Published: 2011

Journal Articles

Evaluation of Atypical Low Energy Fractures in Patients Affected by Multiple Myeloma Treated with Bispohosphonates

Samantha Pozzi, MD, Raffaella Marcheselli, MS, Alessia Bari, MD, Eliana Valentina Liardo, MD, Paola Bresciani, MD, Maria Teresa Donini, MD, Santo Neri, MD, Luciano Masini, Giuseppe Caparrotti, MD, Pellegrino Musto, Elisa Ferraris, MD, Daniela Petro, MD, Luigi Marcheselli, MS, Antonio Palumbo, MD, Stefano Sacchi, MD

Blood (2011) 118 (21): 5134.

https://doi.org/10.1182/blood.V118.21.5134.5134

Published: 2011

Journal Articles

Secondary Malignancies after Treatment of Aggressive Non-Hodgkin Lymphoma: A GISL Cohort Study on 1259 Patients.

Stefano Sacchi, MD, Luigi Marcheselli, MS, Alessia Bari, MD, Raffaella Marcheselli, BS, Samantha Pozzi, MD, Giovanni Quarta, MD, Nicola Di Renzo, MD, Alberto Fragasso, MD, Francesco Angrilli, MD, Massimo Federico, MD

Blood (2007) 110 (11): 522.

https://doi.org/10.1182/blood.V110.11.522.522

Published: 2007

Journal Articles

Incidence and Outcome of Myelodysplastic Syndromes in Province of Modena.

Alessia Bari, MD, Raffaella Marcheselli, BS, Ivan Rashid, BS, Goretta Bonacorsi, MD, Roberto Marasca, MD, Francesca Giacobbi, BS, Patrizia Zucchini, BS, Massimo Federico, MD, Stefano Sacchi, MD

Blood (2007) 110 (11): 4610.

https://doi.org/10.1182/blood.V110.11.4610.4610

Published: 2007

Journal Articles

Incidence and Outcome of Chronic Myeloproliferative Disorders: A Population-Based Study from a Cancer Registry in Northern Italy.

Alessia Bari, MD, Raffaella Marcheselli, BS, Ivan Rashid, BS, Goretta Bonacorsi, MD, Orsola Bonanno, MD, Paola Temperani, BS, Giovanna Leonardi, MD, Massimo Federico, MD, Stefano Sacchi, MD

Blood (2007) 110 (11): 4650.

https://doi.org/10.1182/blood.V110.11.4650.4650

Published: 2007

Journal Articles

Introduction of Combined Chemotherapies Plus Rituximab (R) Has Improved Outcome of Previously Untreated and Relapsed Follicular Lymphoma (FL) Patients (pts).

Stefano Sacchi, MD, Samantha Pozzi, MD, Luigi Marcheselli, BS, Alessia Bari, MD, Stefano Luminari, MD, Massimo Federico, MD, Francesco Angrilli, MD, Marco Lombardo, MD, Chiara Broglia, MD, Giovanni Quarta, MD, Maura Brugiatelli, MD

Blood (2006) 108 (11): 4703.

https://doi.org/10.1182/blood.V108.11.4703.4703

Published: 2006

NARROW

Prognostication of Diffuse Large B-Cell Lymphoma By Lympho2Cx Assay and BCL2 and MYC Expression: Application in a Real Life Context of 154 Patients

Absolute Monocyte Count at Diagnosis Could Improve the Prognostic Role of Final FDG-PET in Diffuse Large B Cell Lymphoma Patients

Prognostic Score Based on Clinical and Biochemical Surrogates of Disease Status in DLBCL Trated with Chemo-Immunotherapy

Prognostic Role of Serum Albumin Level in DLBCL before and during the Rituximab Era. Retrospective GISL Study over 738 Cases

Long-Term Follow-up Analysis of HD2000 Trial Comparing ABVD Versus BEACOPP Versus Copp/EBV/CAD in Patients with Newly Diagnosed Advanced-Stage Hodgkin's Lymphoma: A Study from the Fondazione Italiana Linfomi

Romidepsin and Lenalidomide Show a Synergistic Effect In T–Cell Lymphoma Cell Lines

Are Absolute Monocyte Count and The Lymphocyte-Monocyte Ratio (LMR) Valid Prognostic Factors In Classical Hodgkin Lymphoma? An Evaluation Based On Data From 1079 Patients

Final Results Of a Phase II Study Of Lenalidomide In Combination With Rituximab For The Treatment Of Indolent Non Follicular Non Hodgkin Lymphoma

Monocytosis Has Adverse Prognostic Significance and Impacts Survival in Patients with T-Cell Lymphomas.

In Vitro Combination of Bortezomib with Enzastaurin or Lenalidomide Enhances the Cytotoxicity in B-Cell Lymphoma Cell Lines.

Secondary Leukemia After Non-Hodgkin Lymphoma: A Systematic Review and a Meta-Analysis

Evaluation of Atypical Low Energy Fractures in Patients Affected by Multiple Myeloma Treated with Bispohosphonates

Secondary Malignancies after Treatment of Aggressive Non-Hodgkin Lymphoma: A GISL Cohort Study on 1259 Patients.

Incidence and Outcome of Myelodysplastic Syndromes in Province of Modena.

Incidence and Outcome of Chronic Myeloproliferative Disorders: A Population-Based Study from a Cancer Registry in Northern Italy.

Introduction of Combined Chemotherapies Plus Rituximab (R) Has Improved Outcome of Previously Untreated and Relapsed Follicular Lymphoma (FL) Patients (pts).

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only